Influence of anti-thymocyte globulin plasma levels on outcome parameters in stem cell transplanted children
- 18 March 2020
- journal article
- research article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 83, 106371
- https://doi.org/10.1016/j.intimp.2020.106371
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantationTransplant Immunology, 2012
- IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHDBone Marrow Transplantation, 2011
- Chronic Graft-Versus-Host Disease (GVHD) in ChildrenPediatric Clinics of North America, 2010
- Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation: Results from a Prospective StudyTransplantation and Cellular Therapy, 2009
- Total and Active Rabbit Antithymocyte Globulin (rATG;Thymoglobulin®) Pharmacokinetics in Pediatric Patients Undergoing Unrelated Donor Bone Marrow TransplantationTransplantation and Cellular Therapy, 2009
- Acute graft-versus-host disease in childrenBone Marrow Transplantation, 2007
- Mechanisms of action of antithymocyte globulin: T-cell depletion and beyondLeukemia, 2007
- Antithymocyte Globulin Pharmacokinetics in Pediatric Patients After Hematopoietic Stem Cell TransplantationJournal of Pediatric Hematology/Oncology, 2005
- Increased incidence of EBV‐related disease following paediatric stem cell transplantation with reduced‐intensity conditioningBritish Journal of Haematology, 2005
- Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulinBritish Journal of Haematology, 2000